Ended-July 30, 2018 Rating-6.9/10
GlobexSCI(GSI) collects databases of scientific papers into a single array,The ecosystem routes and processes texts and artificial intelligence builds algorithms of selecting relevant content By analyzing the user experience .The content of the articles will be stored in blockchain,
#Platforms
Basic Details- | Financials- | ||
---|---|---|---|
Name of ICO | GlobexSCI | Token– | GSI |
WEBSITE | globexsci.io | presale- | |
Field of work | platform for scientific publications | Mainsale- | Completed |
country | Cyprus | softcap | 3 000 ETH |
Pre-sale - | Completed | hardcap | 60 000 ETH |
Start-end | 2018-02-07 - 2018-03-07 | Total /max | 43,500,000 GSI |
Sale start | April 20, 2018 | Price- | |
Sale ends | July 01, 2018 | Curr Accepted | ETH |
Platform | Ethereum | Eth=/eth | 500 GSI |
Type | ERC20 | Btc=/btc | |
Algorithm used | Min buy | ||
Blockchain used | Yes | Bonuses | Week 1 - 25% |
Nosale country | Week 2 - 20% | ||
Week 3 - 15% | |||
Week 4 - 10% | |||
Week 5 - 5% | |||
Social details- | Whitepaper Download Link | ||
Competition already existing- Yes, (Storj, BCDiploma) | |||
Uniqueness than competitors- non-disclosure of information to third parties, user-friendly updates and interface, provide extended content security | |||
Unique selling point if any- simplify the exchange of academic literature, research results, scholarly manuscripts | |||
Detailed intro of ICO
|
- Creation of storage for scientific papers using our own servers on the basis of available Sci Hub
- database optimizing text search in papers
- setting up a prototype system of science paper storage in blockchain.
- Testing demand through main communication channels and conclusion of preliminary agreements with science communities and universities
- working out communication strategy and advertising campaign for years 2018 – 2019.
- Involvement of three universities via direct sales and engagement of 200 000 science staff members
- refinement of positioning, USP and improvement of product features
- conclusion of contracts with main advertisers in pharmaceutical and biotechnological industries.